Stay updated on EMBARK: Enzalutamide Combo in Nonmetastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the EMBARK: Enzalutamide Combo in Nonmetastatic Prostate Cancer Clinical Trial page.

Latest updates to the EMBARK: Enzalutamide Combo in Nonmetastatic Prostate Cancer Clinical Trial page
- Check7 days agoChange DetectedThe website's footer revision changed from v3.7.1 to v3.7.2.SummaryDifference0.0%

- Check14 days agoChange DetectedThe ClinicalTrials.gov page footer now displays site revision v3.7.1 instead of v3.7.0.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedA new revision entry labeled v3.7.0 has been added to the record history, replacing the previous v3.6.6. This indicates an update to the study record history on ClinicalTrials.gov.SummaryDifference0.0%

- Check56 days agoChange DetectedThe record history gains an entry for v3.6.6 and removes the previous v3.6.5 entry, indicating a version update in the study's release history.SummaryDifference0.0%

- Check77 days agoChange DetectedThe latest version label in the study history updates from Revision: v3.6.4 to Revision: v3.6.5, representing a small frontend build change.SummaryDifference0.0%

- Check92 days agoChange DetectedThe version history now shows Revision: v3.6.4 as the latest entry, replacing v3.6.3; this indicates an interface or metadata update rather than changes to trial content.SummaryDifference0.0%

Stay in the know with updates to EMBARK: Enzalutamide Combo in Nonmetastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EMBARK: Enzalutamide Combo in Nonmetastatic Prostate Cancer Clinical Trial page.